Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Italian Stock Exchange  >  DiaSorin SpA    DIA   IT0003492391

End-of-day quote. End-of-day quote  - 07/27
57.1 EUR   -1.55%
07/27 DIASORIN : Reagents, controls and consumables for automatic immunoas..
07/21DJQUEST DIAGNOSTI : Profit Rises, Helped by Lower Costs
06/29 DIASORIN : Webinar Spotlights Evolution of PTH and Vitamin D Testing
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Italian Stock Exchange
07/21/2016 07/22/2016 07/25/2016 07/26/2016 07/27/2016 Date
57.05(c) 56.95(c) 57.75(c) 58(c) 57.1 Last
17 674 47 333 55 081 54 221 63 617 Volume
-0.61% -0.18% +1.40% +0.43% -1.55% Change
More quotes
Financials (€)
Sales 2016 564 M
EBIT 2016 172 M
Net income 2016 113 M
Finance 2016 123 M
Yield 2016 1,22%
Sales 2017 630 M
EBIT 2017 194 M
Net income 2017 127 M
Finance 2017 98,0 M
Yield 2017 1,34%
P/E ratio 2016 28,41
P/E ratio 2017 25,59
EV / Sales2016 5,54x
EV / Sales2017 5,00x
Capitalization 3 245 M
More Financials
Company
DiaSorin SpA engages in the development, production, and marketing of reagent kits for in vitro diagnostics.Its business segments are the geographic locations in which it operates: Italy and the United Kingdom; Europe which comprises Germany, France, Belgium, the Netherlands, Spain, Portugal,... 
More about the company
Surperformance© ratings of DiaSorin SpA
Trading Rating : Investor Rating :
More Ratings
Latest news on DIASORIN SPA
07/27 DIASORIN : Reagents, controls and consumables for automatic immunoassay analyzer..
07/21DJQUEST DIAGNOSTICS : Profit Rises, Helped by Lower Costs
06/29 DIASORIN : Webinar Spotlights Evolution of PTH and Vitamin D Testing
06/28 DIASORIN : Webinar Spotlights Evolution of PTH and Vitamin D Testing
06/06DJQUEST DIAGNOSTICS : to Move Headquarters to Secaucus
06/02 DIASORIN : Webinar Details How to Define and Assess Parathyroid Functional State..
05/23 DIASORIN SPA : ex-dividend day for annual dividend
04/25 DIASORIN : LabRoots to Host DiaSorin Webinar That Fills in Common Knowledge Gaps..
04/07 DIASORIN : Webinar Spotlights Primary Hyperaldosteronism From A to Z
04/01 DIASORIN : to Acquire Focus Diagnostics Unit for $300 Million
More news
Sector news : Diagnostic & Testing Substances
07/27DJAlere Faces Criminal Probe Over Medicare, Medicaid Billing
07/26DJBAXTER : Results Boosted by Growth in Hospital Products Segment
07/25DJBAXTER : CFOs Turn to Consultants as Challenges Mount
07/22DJDEXCOM : Shares Rise After FDA Panel Vote
07/21DJSTRYKER : Raises Annual Guidance, but Current Quarter's View Misses Targets
More sector news : Diagnostic & Testing Substances
News from SeekingAlpha
03/30 DiaSorin buys Quest's diagnostic products business for $300M
Advertisement
Chart DIASORIN SPA
Duration : Period :
DiaSorin SpA Technical Analysis Chart | DIA | IT0003492391 | 4-Traders
Full-screen chart
Technical analysis trends DIASORIN SPA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 53,7 €
Spread / Average Target -7,5%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Carlo Rosa Chief Executive Officer, Executive Director & GM
Gustavo Denegri Chairman
Piergiorgio Pedron Chief Financial Officer & Senior Corporate VP
Francesco Colotta Chief Medical Officer & Senior Corporate VP
Chen Menachem Even Executive Director & SVP-Commercial Operations
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
DIASORIN SPA17.54%3 568
BIOMERIEUX13.01%5 414
SICHUAN MAKER BIOTECHN..--.--%2 226
NINGBO MEDICALSYSTEM B..--.--%1 822
SHANGHAI KEHUA BIO-ENG..--.--%1 648
GUANGZHOU WONDFO BIOTE..--.--%1 352
More Results